Optum Ventures, a venture capital subsidiary of healthcare provider UnitedHealth Group, invested $7.5m in a $20m round closed by US-based life sciences analytics software developer Shyft Analytics on Wednesday.
The series B round also featured pharmaceutical distributor McKesson, clinical trial analysis software provider Medidata Solutions, Health Enterprise Partners and Milestone Venture Partners.
Shyft has built a cloud data analytics and management platform for life sciences companies that can help accelerate progress in a range of business areas from clinical development to sales.
Zack King, founder and chief executive of Shyft Analytics, said: “The investment from Optum is an affirmation of that value and of our shared view of the exciting and transformative changes happening in healthcare today.
“As our customers become ever more patient-centric, we are partnering with leading companies to develop and deliver the right treatment to the right patient with the best possible outcome.”
Shyft closed the $12.5m first tranche of the round in August 2016, and the completed series B round took its total funding to $39m.
Optum Ventures is directly overseen by Optus, the health IT services subsidiary of UnitedHealth.